Clinical and Translational Science Collaborative of Cleveland
Clinical and Translational Science Collaborative of Cleveland
批准号:
9978966
负责人:
MICHAEL W. KONSTAN
金额:
$672.2万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-05-15 至 2023-04-30
关键词:
Alzheimer&aposs DiseaseBasic ScienceBiotechnologyCitiesClinicClinicalClinical InvestigatorClinical ResearchClinical SciencesClinical TrialsCollaborationsCommon ColdCommunitiesCountryDisadvantagedEnsureEnvironmentFacultyFoundationsFundingGenetic DiseasesGoalsGovernment AgenciesGrantHealthHealth BenefitHealth systemHealthcareHospitalsHumanIncubatedIndividualInfant MortalityInformaticsInstitutionKnowledgeLaboratoriesLeadershipLife ExpectancyLocationLongevityMalignant NeoplasmsMedical centerMethodsModelingMovementNational Research Service AwardsNeighborhoodsNeurodegenerative DisordersPatientsPersonal SatisfactionPopulationPositioning AttributePreparationProcessProgram DevelopmentRecommendationResearchResearch MethodologyResearch SupportResearch TrainingResourcesScienceSiteSolidSystemTNFSF15 geneTestingTimeTrainingTraining SupportTranslational ResearchTranslationsUnderserved PopulationUnited States Department of Veterans AffairsUnited States National Institutes of HealthUniversitiesUniversity HospitalsVisionbasecareer developmentcatalystclinical research sitecollaborative environmentdesignflexibilityhealth disparityimprovedinner cityinnovationmembermulti-site trialnamed groupnext generationnovel therapeuticsoperationprogramsprototyperesearch clinical testingresearch facilitystatisticssuburbsuccesstranslational scientist
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Clinical and translational (C/T) research is essential to bring the discoveries of biomedical science to benefit the
health and well-being of our nation. The Clinical and Translational Science Collaborative (CTSC) of Cleveland,
a collaborative among Case Western Reserve University (CWRU) and its affiliated hospital systems, the
Cleveland Clinic (CC), MetroHealth (MH), University Hospitals (UH), and the Louis Stokes Veterans
Administration Medical Center (VA), aspires to be a catalyst for high quality C/T research both locally and
nationally. The CTSC operates as a fully integrated cooperative, collaborative, and confluent research
environment that supports all aspects of clinical and translational science, enabling full access by university
faculty at all partner institutions to all CTSC-associated potential collaborators and research resources. It has
positioned itself to assume leadership in disseminating best practices and promoting multi-site clinical research.
It now seeks funding to support the development of program support required to advance the goals set forth by
the 2013 recommendations for the CTSA Program by the IOM (now NAM). The CTSC of Cleveland has created
a solid foundation on which to build from, to utilize the power of this collaborative to ensure rigorous and
innovative training of the C/T/ workforce, to accelerate the translation of discoveries to patients, to improve the
health of Cleveland, and to provide scalable models for other locations throughout the nation. To realize its
vision, the CTSC of Cleveland proposes to engage all C/T science stakeholders, the workforce, patients and
community members to collaborate locally, regionally, and nationally, to 1) advance human health, 2) develop
and cultivate the current and next generation C/T research workforce, with special focus on preparation for team
science and increasing the diversity of the workforce, 3) promote integration of our translational processes from
discovery through clinical trials, of our community throughout the research enterprise, and of special and
underserved populations into C/T research across the lifespan, 4) increase the quality and efficiency of C/T
research, particularly multi-site trials, through innovative methods and processes and strong collaboration among
CTSC Hubs, and 5) provide innovative informatics to support the training and research environment both within
the CTSC and nationally. The CTSC has designed an Administrative Core, six C/T research components:
Informatics, Community and Collaboration, Translational Endeavors, Research Methods, Hub Research
Capacity, and Network Capacity; and two formal C/T training cores: Institutional Career Development Core
(KL2), and the NRSA Training Core (TL1) to accomplish its goals. Commitment to collaboration and innovation
in C/T research remain top priorities as the CTSC implements its aims and builds the new iteration of the Clinical
and Translational Science Collaborative of Cleveland.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Research Career Development in Child Health
-
批准号:7994220
-
项目类别:
-
资助金额:$20.21万
-
财政年份:2008
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
Research Career Development in Child Health
-
批准号:8197139
-
项目类别:
-
资助金额:$21.49万
-
财政年份:2008
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
Clinical and Translational Science Collaborative of Cleveland
-
批准号:9093875
-
项目类别:
-
资助金额:$977.48万
-
财政年份:2007
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
Clinical and Translational Science Collaborative of Cleveland
-
批准号:9093876
-
项目类别:
-
资助金额:$222.31万
-
财政年份:2007
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
Clinical Studies
-
批准号:7288639
-
项目类别:
-
资助金额:$21.42万
-
财政年份:2007
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
PTC124 AS AN ORAL TREATMENT FOR NONSENSE-MUTATION-MEDIATED CYSTIC FIBROSIS
-
批准号:7378077
-
项目类别:
-
资助金额:$4.78万
-
财政年份:2006
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
BIIL284BS IN ADULT AND PEDIATRIC CYSTIC FIBROSIS PATIENTS
-
批准号:7202776
-
项目类别:
-
资助金额:$1.01万
-
财政年份:2005
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
ORAL THERACLEC-TOTAL IN CF PATIENTS WITH EXOCRINE PANCREATIC INSUFFICIENCY
-
批准号:7202793
-
项目类别:
-
资助金额:$15.45万
-
财政年份:2005
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
TOBRAMYCIN FOR INHALATION (TOBI) IN YOUNG CHILDREN WITH CYSTIC FIBROSIS
-
批准号:7202765
-
项目类别:
-
资助金额:$0.05万
-
财政年份:2005
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
BIIL284BS in adult and pediatric cystic fibrosis patients
-
批准号:6974994
-
项目类别:
-
资助金额:$3.01万
-
财政年份:2004
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
Oral TheraCLEC-Total in adult and pediatric subjects with cystic fibrosis
-
批准号:6974986
-
项目类别:
-
资助金额:$6.21万
-
财政年份:2004
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
Fat and protein absorption in cystic fibrosis pts with pancreatic insufficiency
-
批准号:6975001
-
项目类别:
-
资助金额:$7.23万
-
财政年份:2004
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
Neutrophil imaging of the lung for characterizing pulmonary infection in CF pts
-
批准号:6974990
-
项目类别:
-
资助金额:$1.21万
-
财政年份:2004
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
PROLASTIN AEROSOL THERAPY IN PATIENTS WITH CYSTIC FIBROSIS
-
批准号:6301071
-
项目类别:
-
资助金额:$14.86万
-
财政年份:2000
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
LUNG SPECIFIC BIOEFFICACY OF ORAL DMP 777 IN ADULTS W/ CF
-
批准号:6305356
-
项目类别:
-
资助金额:$1.92万
-
财政年份:1999
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
CPX (ORAL, MULTIDOSE) IN ADULTS W/ MILD TO MODERATELY SEVERE CYSTIC F
-
批准号:6305371
-
项目类别:
-
资助金额:$1.92万
-
财政年份:1999
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
PROLASTIN AEROSOL THERAPY IN PATIENTS WITH CYSTIC FIBROSIS
-
批准号:6201835
-
项目类别:
-
资助金额:$14.86万
-
财政年份:1999
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
CPX (ORAL, MULTIDOSE) IN ADULTS W/ MILD TO MODERATELY SEVERE CYSTIC F
-
批准号:6264431
-
项目类别:
-
资助金额:$1.92万
-
财政年份:1998
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
PROLASTIN AEROSOL THERAPY IN PATIENTS WITH CYSTIC FIBROSIS
-
批准号:6105187
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1998
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
DMP777 IN ADULT PATIENTS 18 YRS OF AGE AND OLDER WITH CYSTIC FIBROSIS
-
批准号:6115324
-
项目类别:
-
资助金额:$1.92万
-
财政年份:1998
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
国内基金
海外基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
-
批准号:81000622
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:梁胜
-
依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
-
批准号:31060293
-
项目类别:地区科学基金项目
-
资助金额:26.0万元
-
批准年份:2010
-
负责人:郭亚芬
-
依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
-
批准号:30960334
-
项目类别:地区科学基金项目
-
资助金额:22.0万元
-
批准年份:2009
-
负责人:董贵成
-
依托单位: